Relative potencies of flutamide and 'Casodex'

被引：7

作者：

Furr, BJA

机构：

[1] Cardiovasc./Musculoskel. Res. Dept., Zeneca Pharmaceuticals, Mereside, Macclesfield, Cheshire SK10 4TG, Alderley Park

来源：

关键词：

D O I：

10.1677/erc.0.0040197

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：197 / 202

页数：6

共 37 条

[1] STEADY-STATE HYDROXYGLUTAMIDE PLASMA-LEVELS AFTER THE ADMINISTRATION OF 2 DOSAGE FORMS OF FLUTAMIDE [J].

ASADE, RH ;

PRIZONT, L ;

MUINO, JP ;

TESSLER, J .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1991, 27 (05) :401-405

[2] THE EFFECT OF KETOCONAZOLE RELATED IMIDAZOLE DRUGS AND ANTIANDROGENS ON [H-3] R1881 BINDING TO THE PROSTATIC ANDROGEN RECEPTOR AND [H-3]5-ALPHA-DIHYDROTESTOSTERONE AND [H-3] CORTISOL BINDING TO PLASMA-PROTEINS [J].

AYUB, M ;

LEVELL, MJ .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1989, 33 (02) :251-255

[3] PLASMA-LEVELS OF HYDROXY-FLUTAMIDE IN PATIENTS WITH PROSTATIC-CANCER RECEIVING THE COMBINED HORMONAL-THERAPY - AN LHRH AGONIST AND FLUTAMIDE [J].

BELANGER, A ;

GIASSON, M ;

COUTURE, J ;

DUPONT, A ;

CUSAN, L ;

LABRIE, F .

PROSTATE, 1988, 12 (01) :79-84

[4] Androgen receptors in prostate cancer [J].

Bentel, JM ;

Tilley, WD .

JOURNAL OF ENDOCRINOLOGY, 1996, 151 (01) :1-11

[5]

BLACKLEDGE G, 1993, CANCER, V72, P3830, DOI 10.1002/1097-0142(19931215)72:12+<3830::AID-CNCR2820721713>3.0.CO

[6]

2-D

[7]

Blackledge GRP, 1997, EUR UROL, V31, P30

[8] EVALUATION OF A PERIPHERALLY SELECTIVE ANTIANDROGEN (CASODEX) AS A TOOL FOR STUDYING THE RELATIONSHIP BETWEEN TESTOSTERONE AND SPERMATOGENESIS IN THE RAT [J].

CHANDOLIA, RK ;

WEINBAUER, GF ;

BEHRE, HM ;

NIESCHLAG, E .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1991, 38 (03) :367-375

[9] THE PHARMACOKINETICS OF CASODEX ENANTIOMERS IN SUBJECTS WITH IMPAIRED LIVER-FUNCTION [J].

COCKSHOTT, ID ;

SOTANIEMI, EA ;

COOPER, KJ ;

JONES, DC .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 36 (04) :339-343

[10]

COCKSHOTT ID, 1990, EUR UROL, V18, P10

← 1 2 3 4 →